195 related articles for article (PubMed ID: 24107826)
1. [Endometrial cancer in young patients: report of 17 cases].
Dudnyikova A; Horváth K; Pete I
Magy Onkol; 2013 Sep; 57(3):203-6. PubMed ID: 24107826
[TBL] [Abstract][Full Text] [Related]
2. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Vinker S; Shani A; Open M; Fenig E; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):63-5. PubMed ID: 10221612
[TBL] [Abstract][Full Text] [Related]
3. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
Wang HY; Shen L; Sun Z
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
[TBL] [Abstract][Full Text] [Related]
4. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
5. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.
Gonthier C; Walker F; Luton D; Yazbeck C; Madelenat P; Koskas M
Gynecol Oncol; 2014 Apr; 133(1):33-7. PubMed ID: 24680589
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Gungor T; Cetinkaya N; Yalcin H; Zergeroglu S; Erkaya S
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):309-13. PubMed ID: 27343306
[TBL] [Abstract][Full Text] [Related]
7. Sparing fertility in young patients with endometrial cancer.
Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
[TBL] [Abstract][Full Text] [Related]
8. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
Park JY; Nam JH
Oncologist; 2015 Mar; 20(3):270-8. PubMed ID: 25673106
[TBL] [Abstract][Full Text] [Related]
9. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
10. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
11. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
12. [Endometrial adenocarcinoma and clear cell carcinoma in a young woman with polycystic ovarian syndrome: a case report].
Niu J; Liu N; Liu GB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):733-4. PubMed ID: 27222196
[TBL] [Abstract][Full Text] [Related]
13. Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer.
Salha O; Martin-Hirsch P; Lane G; Sharma V
Hum Reprod; 1997 May; 12(5):959-62. PubMed ID: 9194647
[TBL] [Abstract][Full Text] [Related]
14. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
15. Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy.
Kung FT; Chen WJ; Chou HH; Ko SF; Chang SY
Hum Reprod; 1997 Aug; 12(8):1649-53. PubMed ID: 9308787
[TBL] [Abstract][Full Text] [Related]
16. Endometrial cancer and fertility.
Rackow BW; Arici A
Curr Opin Obstet Gynecol; 2006 Jun; 18(3):245-52. PubMed ID: 16735822
[TBL] [Abstract][Full Text] [Related]
17. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis.
Fan Z; Li H; Hu R; Liu Y; Liu X; Gu L
Int J Gynecol Cancer; 2018 Feb; 28(2):385-393. PubMed ID: 29266019
[TBL] [Abstract][Full Text] [Related]
18. Endometrial adenocarcinoma in a young woman.
Caserta D; Bordi G; Scarani S; Moscarini M
Eur J Gynaecol Oncol; 2013; 34(2):179-82. PubMed ID: 23781594
[TBL] [Abstract][Full Text] [Related]
19. Micronized estradiol and progesterone therapy in primary, preinvasive endometrial cancer (1A/G1) in young women with polycystic ovarian syndrome.
Stanosz S; von Mach-Szczypiński J; Sieja K; Koœciuszkiewicz J
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2472-6. PubMed ID: 25157541
[TBL] [Abstract][Full Text] [Related]
20. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
